Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to $8.8 million.

  • Tandem Diabetes Care's Non-Current Deffered Revenue fell 2119.51% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 2119.51%. This contributed to the annual value of $10.5 million for FY2024, which is 2157.38% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Non-Current Deffered Revenue stood at $8.8 million for Q3 2025, which was down 2119.51% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Non-Current Deffered Revenue ranged from a high of $19.1 million in Q3 2022 and a low of $8.8 million during Q3 2025
  • For the 5-year period, Tandem Diabetes Care's Non-Current Deffered Revenue averaged around $13.8 million, with its median value being $13.7 million (2023).
  • Per our database at Business Quant, Tandem Diabetes Care's Non-Current Deffered Revenue plummeted by 38.96% in 2022 and then crashed by 2640.13% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Non-Current Deffered Revenue (Quarter) stood at $16.9 million in 2021, then decreased by 0.39% to $16.9 million in 2022, then fell by 21.0% to $13.3 million in 2023, then dropped by 21.57% to $10.5 million in 2024, then dropped by 15.61% to $8.8 million in 2025.
  • Its Non-Current Deffered Revenue was $8.8 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.9 million in Q1 2025.